Ishita Drugs And Industries (BOM:524400) Piotroski F-Score: 7 (As of Sep. 05, 2026) — 40% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524400 Ishita Drugs And Industries Ltd BOM:524400
72 GF Score
Price ₹72.90
GF Value ₹64.94
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ishita Drugs And Industries Piotroski F-Score?

Ishita Drugs And Industries BOM:524400 +2.85% 72 Piotroski F-Score is 7 as of Sep. 05, 2026, which is 40% above its 10-year median of 5.00. GuruFocus rates BOM:524400 with a GF Score™ of 72/100 and a GF Value™ of ₹64.94 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 986 Drug Manufacturers companies, Ishita Drugs And Industries ranks better than 78.6% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ishita Drugs And Industries has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Ishita Drugs And Industries's Piotroski F-Score or its related term are showing as below:

BOM:524400' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of Ishita Drugs And Industries was 8. The lowest was 4. And the median was 5.

Ishita Drugs And Industries  (BOM:524400) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Ishita Drugs And Industries Piotroski F-Score Related Terms


Ishita Drugs And Industries Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Ishita Drugs And Industries's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ishita Drugs And Industries Piotroski F-Score Chart

Ishita Drugs And Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 8.00 5.00 7.00

Ishita Drugs And Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 7.00 0.00

BOM:524400 vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ishita Drugs And Industries Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Ishita Drugs And Industries's Piotroski F-Score falls into.


BOM:524400
72GF Score
Ishita Drugs And Industries Ltd BOM:524400
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹7.8 Mil.
Cash Flow from Operations was ₹39.2 Mil.
Revenue was ₹146.6 Mil.
Gross Profit was ₹38.9 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (162.958 + 126.037) / 2 = ₹144.4975 Mil.
Total Assets at the begining of this year (Mar25) was ₹163.0 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.3 Mil.
Total Current Assets was ₹95.4 Mil.
Total Current Liabilities was ₹9.9 Mil.
Net Income was ₹8.7 Mil.

Revenue was ₹150.0 Mil.
Gross Profit was ₹37.2 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (108.087 + 162.958) / 2 = ₹135.5225 Mil.
Total Assets at the begining of last year (Mar24) was ₹108.1 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.9 Mil.
Total Current Assets was ₹149.8 Mil.
Total Current Liabilities was ₹54.0 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ishita Drugs And Industries's current Net Income (TTM) was 7.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ishita Drugs And Industries's current Cash Flow from Operations (TTM) was 39.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=7.785/162.958
=0.04777305

ROA (Last Year)=Net Income/Total Assets (Mar24)
=8.681/108.087
=0.08031493

Ishita Drugs And Industries's return on assets of this year was 0.04777305. Ishita Drugs And Industries's return on assets of last year was 0.08031493. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Ishita Drugs And Industries's current Net Income (TTM) was 7.8. Ishita Drugs And Industries's current Cash Flow from Operations (TTM) was 39.2. ==> 39.2 > 7.8 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0.345/144.4975
=0.00238758

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0.894/135.5225
=0.00659669

Ishita Drugs And Industries's gearing of this year was 0.00238758. Ishita Drugs And Industries's gearing of last year was 0.00659669. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=95.422/9.885
=9.65321194

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=149.835/54.048
=2.77225799

Ishita Drugs And Industries's current ratio of this year was 9.65321194. Ishita Drugs And Industries's current ratio of last year was 2.77225799. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Ishita Drugs And Industries's number of shares in issue this year was 2.99. Ishita Drugs And Industries's number of shares in issue last year was 2.99. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=38.929/146.602
=0.26554208

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=37.219/149.973
=0.24817134

Ishita Drugs And Industries's gross margin of this year was 0.26554208. Ishita Drugs And Industries's gross margin of last year was 0.24817134. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=146.602/162.958
=0.89963058

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=149.973/108.087
=1.38752116

Ishita Drugs And Industries's asset turnover of this year was 0.89963058. Ishita Drugs And Industries's asset turnover of last year was 1.38752116. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+1+0
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ishita Drugs And Industries has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Ishita Drugs And Industries (BOM:524400) has a Piotroski F-Score of 7 as of Sep. 05, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ishita Drugs And Industries and its competitors. This is 40% above median its historical median of 5.00. Over the past decade, Ishita Drugs And Industries' Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Ishita Drugs And Industries ranks #211 out of 986 companies in the Drug Manufacturers industry, placing it in the top 21.4%.
Is Ishita Drugs And Industries' Piotroski F-Score too high?
Ishita Drugs And Industries' current Piotroski F-Score of 7 is 40% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Ishita Drugs And Industries' value of 7 is 40% above this industry median. Based on the distribution chart, Ishita Drugs And Industries ranks #211 out of 986 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ishita Drugs And Industries has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ishita Drugs And Industries ranks #211 out of 986 companies for Piotroski F-Score. This places Ishita Drugs And Industries in the top 21% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Ishita Drugs And Industries' value of 7 is 40% above this benchmark. Historically, Ishita Drugs And Industries' own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Ishita Drugs And Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 986 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ishita Drugs And Industries's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ishita Drugs And Industries and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ishita Drugs And Industries's current Piotroski F-Score is 7, which is 40% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹64.94, compared to a current price of ₹72.90 — trading 12.3% above its estimated fair value. The current Piotroski F-Score is 7, which is 40% above median its 10-year median of 5.00 and 40% above the Drug Manufacturers industry median of 5.00. Ishita Drugs And Industries' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Piotroski F-Score is 7 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?

Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be overvalued. The current stock price of ₹72.90 is trading 12.3% above its estimated GF Value™ of ₹64.94. GuruFocus considers Ishita Drugs And Industries to be Modestly Overvalued.

Key valuation signals for BOM:524400:

  • Piotroski F-Score: 7 (40% above median its 10-year median of 5.00)
  • GF Value™: ₹64.94 vs. price of ₹72.90 (12.3% above fair value)
  • GF Score™: 72/100 with 5 warning signs
  • Industry Position: 40% above the Drug Manufacturers median (#211 of 986)

No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ishita Drugs And Industries Business Description

Address C.G. Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
72GF Score

Get the complete analysis for BOM:524400

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹72.90
Price
₹64.94
GF Value